Podcast: Immune Persistence After Primary Vaccination with MenQuadfi.

Infect Dis Ther · 2026 · PMC13350569 · PMID 42252361

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In participants who had originally been primed with MenQuadfi, both the post-booster antibody levels and seroprotection rates were higher, or there was at least a clear trend towards higher response compared with those primed with a polysaccharide meningococcal vaccine [ 17 , 23 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.